SARS News and Research

RSS
Super-antibody UT28K shows broad-spectrum activity against SARS-CoV-2 variants

Super-antibody UT28K shows broad-spectrum activity against SARS-CoV-2 variants

15 May 2022
Scientists examine the impact of herpesviruses on (pre)diabetes

Scientists examine the impact of herpesviruses on (pre)diabetes

15 May 2022
What role do children play in household transmission of COVID-19?

What role do children play in household transmission of COVID-19?

14 May 2022
CDC study reveals hybrid SARS-CoV-2 spike from Delta/Omicron recombination event

CDC study reveals hybrid SARS-CoV-2 spike from Delta/Omicron recombination event

14 May 2022
Artificial proteins as specific and versatile neutralizing binders targeting the spike of SARS-CoV-2

Artificial proteins as specific and versatile neutralizing binders targeting the spike of SARS-CoV-2

13 May 2022
The longitudinal progression of health outcomes in COVID-19 survivors with different initial disease severity

The longitudinal progression of health outcomes in COVID-19 survivors with different initial disease severity

13 May 2022
The safety, immunogenicity, and efficacy of the mRNA-1273 vaccine in children aged 6-11

The safety, immunogenicity, and efficacy of the mRNA-1273 vaccine in children aged 6-11

13 May 2022
Multicenter study determines the efficacy of SARS-CoV-2 vaccination against Post-Acute Sequelae of COVID-19

Multicenter study determines the efficacy of SARS-CoV-2 vaccination against Post-Acute Sequelae of COVID-19

13 May 2022
Study explores macromolecular viral entry inhibitors as broad-spectrum first-line antivirals with anti-SARS-CoV-2 activities

Study explores macromolecular viral entry inhibitors as broad-spectrum first-line antivirals with anti-SARS-CoV-2 activities

13 May 2022
Researchers identify compounds from Aspergillus that may be effective against SARS-CoV-2

Researchers identify compounds from Aspergillus that may be effective against SARS-CoV-2

13 May 2022
Investigating effectiveness of mRNA booster against SARS-CoV-2 Omicron in individuals primed with mRNA or inactivated virus vaccines

Investigating effectiveness of mRNA booster against SARS-CoV-2 Omicron in individuals primed with mRNA or inactivated virus vaccines

13 May 2022
Exploring short-term effectiveness of COVID-19 booster vaccine and stable CD8+ T cell memory after three doses

Exploring short-term effectiveness of COVID-19 booster vaccine and stable CD8+ T cell memory after three doses

13 May 2022
Development of a novel surface plasmon resonance-based assay to determine kinetics of SARS-CoV-2 spike – human ACE2 interaction

Development of a novel surface plasmon resonance-based assay to determine kinetics of SARS-CoV-2 spike – human ACE2 interaction

13 May 2022
Study reveals serum proteomic signatures of long COVID patients

Study reveals serum proteomic signatures of long COVID patients

13 May 2022
Dogs can detect SARS-CoV-2 from an individual's sweat

Dogs can detect SARS-CoV-2 from an individual's sweat

12 May 2022
Bayesian viral allele selection for SARS-CoV-2 genomic surveillance

Bayesian viral allele selection for SARS-CoV-2 genomic surveillance

12 May 2022
An Ad5 vectored COVID vaccine expressing an S1-N fusion protein

An Ad5 vectored COVID vaccine expressing an S1-N fusion protein

12 May 2022
Cost-effective ovine antibody-based therapy against SARS-CoV-2 infection

Cost-effective ovine antibody-based therapy against SARS-CoV-2 infection

12 May 2022
T-cell responses after COVID-19 and vaccinations

T-cell responses after COVID-19 and vaccinations

12 May 2022
Enzyme discovery offers new way to regulate cell death process for inflammatory diseases

Enzyme discovery offers new way to regulate cell death process for inflammatory diseases

12 May 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback